- Home
- TCBS vs TARA Comparison
TCBS vs TARA Comparison
Compare TCBS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- TARA
- Stock Information
- Founded
- TCBS 1934
- TARA N/A
- Country
- TCBS United States
- TARA United States
- Employees
- TCBS N/A
- TARA N/A
- Industry
- TCBS Banks
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCBS Finance
- TARA Health Care
- Exchange
- TCBS Nasdaq
- TARA Nasdaq
- Market Cap
- TCBS 46.9M
- TARA 52.4M
- IPO Year
- TCBS N/A
- TARA N/A
- Fundamental
- Price
- TCBS $15.16
- TARA $5.30
- Analyst Decision
- TCBS
- TARA Strong Buy
- Analyst Count
- TCBS 0
- TARA 3
- Target Price
- TCBS N/A
- TARA $22.67
- AVG Volume (30 Days)
- TCBS 4.7K
- TARA 6.6M
- Earning Date
- TCBS 11-13-2024
- TARA 11-12-2024
- Dividend Yield
- TCBS 1.07%
- TARA N/A
- EPS Growth
- TCBS N/A
- TARA N/A
- EPS
- TCBS N/A
- TARA N/A
- Revenue
- TCBS $9,858,000.00
- TARA N/A
- Revenue This Year
- TCBS N/A
- TARA N/A
- Revenue Next Year
- TCBS N/A
- TARA N/A
- P/E Ratio
- TCBS N/A
- TARA N/A
- Revenue Growth
- TCBS N/A
- TARA N/A
- 52 Week Low
- TCBS $12.61
- TARA $1.60
- 52 Week High
- TCBS $15.24
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- TCBS 73.88
- TARA 63.59
- Support Level
- TCBS $14.90
- TARA $5.27
- Resistance Level
- TCBS $15.18
- TARA $6.39
- Average True Range (ATR)
- TCBS 0.08
- TARA 0.89
- MACD
- TCBS 0.02
- TARA 0.05
- Stochastic Oscillator
- TCBS 100.00
- TARA 36.25
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).